ADCT-701

N/A

Report date: 2024/04/18 13:54:25

Base Information

Drug NameADCT-701
Drug Alias NameHumanized anti-DLK1 antibody ADCADCT-701ADCT701LIV-1205 ADC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VA linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > PBD dimer SG3199 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionProtein delta homolog 1 inhibitorsDNA cross linking agents
TargetsProtein delta homolog 1DNA
Therapy Area/IndicationsSmall Cell Lung CarcinomaLiver NeoplasmsAdrenocortical Carcinoma +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAdc Therapeutics SaCancer Research Technology
China Registration ClassN/A

Develop Information

Active CompaniesAdc Therapeutics SaNational Cancer Institute
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaLiver NeoplasmsAdrenocortical Carcinoma +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A